Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR1627Referred to Committee

TREATS Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-02-26
Introduced
31
Cosponsors
HR
ⓘ
Type

Sponsor

Donald Norcross
Donald Norcross
Democrat · NJ · Representative
Votes with party: 97.6% (462 recorded votes)

Full profile: /officials/N000188

Source: Congress.gov · FEC

Cosponsors (31)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Brian K. Fitzpatrick (R-PA-1)Original· 2025-02-26
  • Brittany Pettersen (D-CO-7)· 2025-03-04
  • Carol D. Miller (R-WV-1)· 2025-03-04
  • Chrissy Houlahan (D-PA-6)· 2025-03-04
  • Christopher R. Deluzio (D-PA-17)· 2025-03-04
  • Claudia Tenney (R-NY-24)· 2025-03-04
  • Debbie Dingell (D-MI-6)· 2025-03-04
  • Debbie Wasserman Schultz (D-FL-25)· 2025-03-04
  • Don Bacon (R-NE-2)· 2025-03-04
  • Donald G. Davis (D-NC-1)· 2025-03-04
  • Henry C. "Hank" Johnson, Jr. (D-GA-4)· 2025-03-04
  • Jay Obernolte (R-CA-23)· 2025-03-04
  • Jill N. Tokuda (D-HI-2)· 2025-03-04
  • Jonathan L. Jackson (D-IL-1)· 2025-03-04
  • Josh Harder (D-CA-9)· 2025-03-04
  • Lori Trahan (D-MA-3)· 2025-03-04
  • Mary Gay Scanlon (D-PA-5)· 2025-03-04
  • Michael Lawler (R-NY-17)· 2025-03-04
  • Nanette Diaz Barragán (D-CA-44)· 2025-03-04
  • Paul Tonko (D-NY-20)· 2025-03-04
  • Seth Moulton (D-MA-6)· 2025-03-04
  • Steve Cohen (D-TN-9)· 2025-03-04
  • William R. Keating (D-MA-9)· 2025-03-04
  • Glenn Thompson (R-PA-15)· 2025-04-29
  • Jennifer A. Kiggans (R-VA-2)· 2025-09-10
  • Becca Balint (D-VT)· 2025-09-15
  • Sam T. Liccardo (D-CA-16)· 2025-10-08
  • Angie Craig (D-MN-2)· 2025-10-24
  • Ritchie Torres (D-NY-15)· 2026-04-15

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-02-26

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2025-02-26
  • House Committee on the JudiciaryReferred To · 2025-02-26

Previously

  • Judiciary CommitteeReferred To · 2025-02-26
  • Energy and Commerce CommitteeReferred To · 2025-02-26

Plain-English Summary

Telehealth Response for E-prescribing Addiction Therapy Services Act or the TREATS Act This bill permanently allows health care practitioners to prescribe certain controlled substances for treating substance use disorders via telehealth without evaluating the patient in person. Generally, a health care practitioner may not prescribe a controlled substance via telehealth unless they first conduct an in-person medical evaluation. Federal regulations currently provide a temporary exception to this requirement, allowing practitioners to prescribe schedule II-V controlled substances for legitimate medical purposes (such as treating substance use disorders) via telehealth without an in-person evaluation. However, this temporary regulatory flexibility expires on December 31, 2025. The bill permanently allows practitioners to prescribe schedule III-V controlled substances for the treatment of a substance use disorder via telehealth without conducting an in-person evaluation. In such instances, a practitioner may conduct a telehealth evaluation using audio-only or audio and video equipment.

Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HRES1140Providing for consideration of the bill (H.R. 5408) to accelerate workplace time-to-contract under the National Labor Relations Act.
    Referred to Committee · 2026-05-20
  • HR7471Give America a Raise Act
    Referred to Committee · 2026-02-10
  • HR7116SEPSIS Act
    Referred to Committee · 2026-01-15
  • HR5970Save Our Ships Act
    Referred to Committee · 2025-11-07